InvestorsHub Logo

blue finch

07/28/16 9:01 AM

#70808 RE: Sold2early #70805

It's possible Missling threatened to leave avxl and the BOD had to come up with some $$ to keep him

If he doesn't find $ to continue

Who knows what happens
The clock is ticking

My hope is a partner with deep pockets

This stock share price goes up eventually regardless
From here

Jimbo50

07/28/16 9:05 AM

#70810 RE: Sold2early #70805

Yes and with a much larger group of patients we may identify a subset where long term stabilization may occur or quantifiable reversal

Cbdpotential

07/28/16 9:18 AM

#70819 RE: Sold2early #70805

Well said
I hope so

Remember the comments about patients lives improving and not necessarily focusing on the data?

I too think it's more important to ask if the patient and loved ones benefit from the drug

Improvement in SOC should not be downplayed due to unrealistic expectations

AD SOC is terrible
Anavex is shedding light on the disease in ways nobody has ever seen
and looks, to me, like improving SOC is possible
Combination therapies and EARLY intervention and PREVENTION could serve vital in combating this disease,
and MANY others...

In hindsight, we must remember the extraordinary
In contemplation, we must forget the distractions

Anavex has MUCH more going for it than recent memory may serve ;-)

-
To everyone who messaged me,
I ran out of posts early in the day yesterday
I do not have PM